High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons

HM Al-Kuraishy, AI Al-Gareeb, L Alkazmi… - …, 2022 - Springer
High-mobility group box 1 (HMGB1), a multifunctional nuclear protein, exists mainly within
the nucleus of all mammal eukaryotic cells. It is actively secreted by the necrotic cells as a …

Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients

C Giacomelli, R Piccarducci, L Marchetti… - Biochemical …, 2021 - Elsevier
Pulmonary fibrosis (PF) is characterised by several grades of chronic inflammation and
collagen deposition in the interalveolar space and is a hallmark of interstitial lung diseases …

Resolvin T-series reduce neutrophil extracellular traps

N Chiang, M Sakuma, AR Rodriguez… - Blood, The Journal …, 2022 - ashpublications.org
The newly identified 13-series (T-series) resolvins (RvTs) regulate phagocyte functions and
accelerate resolution of infectious inflammation. Because severe acute respiratory syndrome …

[HTML][HTML] Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect …

JW Martha, R Pranata, MA Lim, A Wibowo… - International Journal of …, 2021 - Elsevier
Background This study aimed to investigate whether the active prescription of low-dose
aspirin during or prior to hospitalization affects mortality in patients with coronavirus disease …

[HTML][HTML] Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients

C Diaz-Arocutipa, B Melgar-Talavera… - International Journal of …, 2021 - Elsevier
Objectives There is conflicting evidence about the efficacy of statin use in regard to clinical
outcomes in patients with coronavirus disease 2019 (COVID-19). A systematic review and …

[HTML][HTML] The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis

I Wijaya, R Andhika, I Huang, A Purwiga… - … epidemiology and global …, 2021 - Elsevier
Background Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a
sensible approach. However, several previous studies showed conflicting results. This meta …

Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study

A Santosa, S Franzén, J Nåtman, B Wettermark… - Scientific Reports, 2022 - nature.com
The impact of statins on COVID-19 remains unclear. This study aims to investigate whether
statin exposure assessed both in the population and in well-defined cohorts of COVID-19 …

Alterations of lipid profile in COVID-19: a narrative review

A Rezaei, S Neshat, K Heshmat-Ghahdarijani - Current Problems in …, 2022 - Elsevier
The COVID-19 pandemic has led to over 100 million infections and over 3 million deaths
worldwide. Understanding its pathogenesis is crucial to guide prognostic and therapeutic …

Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label …

HG Gaitán-Duarte, C Álvarez-Moreno… - …, 2022 - thelancet.com
Background The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in
hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The …

Acute respiratory distress syndrome and COVID-19: A literature review

M Hussain, S Khurram Syed, M Fatima… - Journal of …, 2021 - Taylor & Francis
Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …